MedPath
TGA Approval

ENHERTU trastuzumab deruxtecan 100 mg powder for injection vial (343262)

343262

ENHERTU trastuzumab deruxtecan 100 mg powder for injection vial

AstraZeneca Pty Ltd

October 8, 2021

Medicine

Medicine

Active

Registered - Prescription Injectable

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/d7f5c4f9e240ba81d8a12d67fbea99cb.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/0e7e6297ed1c4a8903cd3c7bb3b90945.pdf

Active Ingredients

trastuzumab deruxtecan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENHERTU trastuzumab deruxtecan 100 mg powder for injection vial (343262) - TGA 批准文号 | MedPath